Kaplan–Meier survival analysis of the 465 cases revealed that breast cancer samples with higher THEMIS2 levels were correlated with significantly poorer survival than were those with lower THEMIS2 levels (Fig. 7B). This evidence concerns the gene THEMIS2 and breast carcinoma.